125 related articles for article (PubMed ID: 23780926)
21. The Glasgow Prognostic Score (GPS) as a novel and significant predictor of extranodal natural killer/T-cell lymphoma, nasal type.
Li YJ; Jiang WQ; Huang JJ; Xia ZJ; Huang HQ; Li ZM
Am J Hematol; 2013 May; 88(5):394-9. PubMed ID: 23423859
[TBL] [Abstract][Full Text] [Related]
22. Development of new prognostic model based on pretreatment βLRI and LLRI for stage IE/IIE upper aerodigestive tract ENKTL, nasal type.
Dai W; Jia B; Yang J; Zhou S; Liu P; He X; Qin Y; Gui L; Zhang C; Han X; Sun Y; Shi Y
Oncotarget; 2017 May; 8(21):34787-34795. PubMed ID: 28410236
[TBL] [Abstract][Full Text] [Related]
23. NF-kappaB activation through the alternative pathway correlates with chemoresistance and poor survival in extranodal NK/T-cell lymphoma, nasal type.
Liu X; Wang B; Ma X; Guo Y
Jpn J Clin Oncol; 2009 Jul; 39(7):418-24. PubMed ID: 19395464
[TBL] [Abstract][Full Text] [Related]
24. Retrospective analysis of treatment outcomes for extranodal NK/T-cell lymphoma (ENKL), nasal type, stage I-IIE: single institute experience of combined modality treatment for early localized nasal extranodal NK/T-cell lymphoma (ENKL).
Lee J; Cho SG; Chung SM; Ryu MR; Kim SH; Jang HS; Choi BO
Ann Hematol; 2013 Mar; 92(3):333-43. PubMed ID: 23180438
[TBL] [Abstract][Full Text] [Related]
25. [Radiation therapy of sinonasal natural killer/T-cell lymphoma].
Riet FG; Canova CH; Gabarre J; Ben Hassine S; Kamsu Kom L; Mazeron JJ; Feuvret L
Cancer Radiother; 2014 Mar; 18(2):147-53; quiz 161, 163. PubMed ID: 24462054
[TBL] [Abstract][Full Text] [Related]
26. [Prognostic factors and treatment outcome in early stage nasal NK/T cell lymphoma].
Yao B; Li YX; Fang H; Yu ZH; Jin J; Liu XF
Zhonghua Xue Ye Xue Za Zhi; 2006 Apr; 27(4):222-5. PubMed ID: 16875550
[TBL] [Abstract][Full Text] [Related]
27. Clinical features and survival of extranodal natural killer/T cell lymphoma with and without hemophagocytic syndrome.
Jia J; Song Y; Lin N; Liu W; Ping L; Zheng W; Wang X; Xie Y; Tu M; Zhang C; Ying Z; Deng L; Ding N; Zhu J
Ann Hematol; 2016 Dec; 95(12):2023-2031. PubMed ID: 27595760
[TBL] [Abstract][Full Text] [Related]
28. New prognostic model for extranodal natural killer/T cell lymphoma, nasal type.
Cai Q; Luo X; Zhang G; Huang H; Huang H; Lin T; Jiang W; Xia Z; Young KH
Ann Hematol; 2014 Sep; 93(9):1541-9. PubMed ID: 24782120
[TBL] [Abstract][Full Text] [Related]
29. CD30-positive cutaneous extranodal natural killer/T-cell lymphoma: clinicopathological features and survival outcomes.
Lee WJ; Moon IJ; Shin HJ; Won CH; Chang SE; Choi JH; Lee MW
Int J Dermatol; 2019 Jun; 58(6):688-696. PubMed ID: 30597548
[TBL] [Abstract][Full Text] [Related]
30. [Clinical study of extranodal NK-T cell lymphoma-nasal type].
Wang H; Li XJ; Zhang SW; Xi Y
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2005 Nov; 40(11):850-4. PubMed ID: 16408753
[TBL] [Abstract][Full Text] [Related]
31. [Exploration of prognostic factors in extranodal nasal-type NK/T cell lymphoma].
Han DM; Chen XQ; Bai QX
Zhonghua Zhong Liu Za Zhi; 2006 Feb; 28(2):137. PubMed ID: 16750021
[No Abstract] [Full Text] [Related]
32. Prognostic nomogram for overall survival in previously untreated patients with extranodal NK/T-cell lymphoma, nasal-type: a multicenter study.
Yang Y; Zhang YJ; Zhu Y; Cao JZ; Yuan ZY; Xu LM; Wu JX; Wang W; Wu T; Lu B; Zhu SY; Qian LT; Zhang FQ; Hou XR; Liu QF; Li YX
Leukemia; 2015 Jul; 29(7):1571-7. PubMed ID: 25697894
[TBL] [Abstract][Full Text] [Related]
33. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
[TBL] [Abstract][Full Text] [Related]
34. Ki-67 expression is predictive of prognosis in patients with stage I/II extranodal NK/T-cell lymphoma, nasal type.
Kim SJ; Kim BS; Choi CW; Choi J; Kim I; Lee YH; Kim JS
Ann Oncol; 2007 Aug; 18(8):1382-7. PubMed ID: 17693651
[TBL] [Abstract][Full Text] [Related]
35. Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211.
Yamaguchi M; Tobinai K; Oguchi M; Ishizuka N; Kobayashi Y; Isobe Y; Ishizawa K; Maseki N; Itoh K; Usui N; Wasada I; Kinoshita T; Ohshima K; Matsuno Y; Terauchi T; Nawano S; Ishikura S; Kagami Y; Hotta T; Oshimi K
J Clin Oncol; 2009 Nov; 27(33):5594-600. PubMed ID: 19805668
[TBL] [Abstract][Full Text] [Related]
36. Absolute lymphocyte count is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type.
Huang JJ; Jiang WQ; Lin TY; Huang Y; Xu RH; Huang HQ; Li ZM
Ann Oncol; 2011 Jan; 22(1):149-155. PubMed ID: 20595450
[TBL] [Abstract][Full Text] [Related]
37. The enhanced expression of the matrix metalloproteinase 9 in nasal NK/T-cell lymphoma.
Sakata K; Someya M; Omatsu M; Asanuma H; Hasegawa T; Ichimiya S; Hareyama M; Himi T
BMC Cancer; 2007 Dec; 7():229. PubMed ID: 18093334
[TBL] [Abstract][Full Text] [Related]
38. Expression levels of apoptosis-related proteins and Ki-67 in nasal NK / T-cell lymphoma.
Yasuda H; Sugimoto K; Imai H; Isobe Y; Sasaki M; Kojima Y; Nakamura S; Oshimi K
Eur J Haematol; 2009 Jan; 82(1):39-45. PubMed ID: 18778369
[TBL] [Abstract][Full Text] [Related]
39. [Prognostic analysis of patients with nasal-type NK/T-cell non-Hodgkin's lymphoma--a report of 93 cases].
Pan ZH; Huang HQ; Lin XB; Xia YF; Xia ZJ; Peng YL; Cai QQ; Lin TY; Jiang WQ; Guan ZZ
Ai Zheng; 2005 Dec; 24(12):1493-7. PubMed ID: 16351799
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors for classifying extranodal NK/T cell lymphoma, nasal type, as lymphoid neoplasia.
Na II; Kang HJ; Park YH; Lee SS; Yoo HJ; Choe DH; Ryoo BY; Yang SH
Eur J Haematol; 2007 Jul; 79(1):1-7. PubMed ID: 17598834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]